As previously announced, SPAR Group entered into the Agreement and Plan of Merger, dated as of August ... Forward Looking Statements This press release (this “Press Release”) contains ...
The deal, presented as a merger of equals, will create a company worth $3.7Bn with annual revenue of around $2Bn.
ReShape also provided an update on the asset purchase agreement with Biorad Medisys. On July 9, 2024, ReShape Lifesciences Inc. entered into a definitive merger agreement with Vyome, under which ...
As previously announced, SPAR Group entered into the Agreement and Plan of Merger, dated as of August 30 ... Forward Looking Statements This press release (this “Press Release”) ...